[1]周 雪,童春帆.血液成分单采和血浆置换治疗血液病的临床疗效观察[J].医学信息,2022,35(08):130-132.[doi:10.3969/j.issn.1006-1959.2022.08.033]
　ZHOU Xue,TONG Chun-fan.Clinical Effect of Single Blood Component Collection and Plasma Exchange in the Treatment of Hematologic Diseases[J].Medical Information,2022,35(08):130-132.[doi:10.3969/j.issn.1006-1959.2022.08.033]
点击复制

血液成分单采和血浆置换治疗血液病的临床疗效观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年08期
页码:
130-132
栏目:
临床研究
出版日期:
2022-04-15

文章信息/Info

Title:
Clinical Effect of Single Blood Component Collection and Plasma Exchange in the Treatment of Hematologic Diseases
文章编号:
1006-1959（2022）08-0130-03
作者:
周 雪; 童春帆
（1.天津市血液中心献血办公室，天津 300110；2.中国医学科学院血液病医院综合诊疗中心外科，天津 300110）
Author(s):
ZHOU Xue; TONG Chun-fan
(1.Blood Donation Office,Tianjin Blood Center,Tianjin 300110,China; 2.Department of Surgery,Comprehensive Diagnosis and Treatment Center of Chinese Academy of Medical Sciences,Tianjin 300110,China)
关键词:
血液成分单采; 血浆置换; 血液病; 血细胞分离机
Keywords:
Single collection of blood components; Plasma exchange; Hematopathy; Blood cell separator
分类号:
R559
DOI:
10.3969/j.issn.1006-1959.2022.08.033
文献标志码:
A
摘要:
目的 观察血液成分单采和血浆置换治疗血液病的临床疗效。方法 选取2019年4月-2021年4月在中国医学科学院血液病医院诊治的140例血液病患者作为研究对象，不同病情患者分别采用血浆置换（n=31）、血液成分单采（红细胞单采28例，白细胞单采51例，血小板单采30例）治疗，观察各治疗方法临床总有效率、血液成分单采患者白细胞计数（WBC）、红细胞计数（RBC）、血红蛋白浓度（Hb）、血细胞比容（HCT）、血小板计数（PLT）和血浆置换患者总蛋白（TP）、清蛋白（ALB）、球蛋白（GLB）、免疫球蛋白（IgG、IgA、IgM）水平，以及临床不良反应发生情况。结果 血浆置换、红细胞单采、白细胞单采、血小板单采总有效率分别为90.32%、100.00%、94.12%、100.00%，差异无统计学意义（P＞0.05）；红细胞单采治疗后患者Hb、RBC、HCT水平均低于治疗前，白细胞单采治疗后患者WBC、PLT水平均低于治疗前，血小板单采治疗后患者PLT水平低于治疗前，差异有统计学意义（P＜0.05）；患者TP、GLB、IgG水平均低于置换前，差异有统计学意义（P＜0.05）；ALB、IgA、IgM水平与置换前比较，差异无统计学意义（P＞0.05）；血液成分单采和血浆置换治疗期间，均未发生严重不良反应。结论 血液成分单采和血浆置换治疗血液病均疗效确切，可改善患者血液指标，且不良反应少，具有良好的应用安全性，可为血液病患者后期治疗奠定良好的基础。
Abstract:
Objective To observe the clinical efficacy of blood component collection and plasma exchange in the treatment of hematologic diseases.Methods A total of 140 patients with hematological diseases diagnosed and treated in the National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital from April 2019 to April 2021 were selected as the research objects. Patients with different conditions were treated with plasma exchange (n=31) and blood component collection (28 cases of red blood cell collection, 51 cases of white blood cell collection, 30 cases of platelet collection). The total effective rate of each treatment method, white blood cell count (WBC), red blood cell count (RBC), hemoglobin concentration (Hb), hematocrit (HCT), platelet count (PLT), total protein (TP), albumin (ALB), globulin (GLB), immunoglobulin (IgG, IgA, IgM) levels of plasma exchange patients, and the occurrence of clinical adverse reactions were observed.Results The total effective rates of plasma exchange, erythrocyte collection, leukocyte collection and platelet collection were 90.32%, 100.00%, 94.12% and 100.00%, respectively, and the difference was not statistically significant (P>0.05). The levels of Hb, RBC and HCT in patients after red blood cellpheresis were lower than those before treatment, the levels of WBC and PLT in patients after white blood cellpheresis were lower than those before treatment, and the PLT level in patients after plateletpheresis was lower than that before treatment, and the difference was statistically significant (P<0.05). The levels of TP, GLB and IgG in patients were lower than those before replacement, and the difference was statistically significant (P<0.05); there was no significant difference in ALB, IgA and IgM levels between before and after replacement (P>0.05). No serious adverse reactions occurred during the treatment of blood component collection and plasma exchange.Conclusion Both blood component collection and plasma exchange are effective in the treatment of hematological diseases, which can improve the blood indexes of patients, reduce adverse reactions, and have good application safety, which can lay a good foundation for the later treatment of patients with hematological diseases.

参考文献/References:

[1]尤建国,宣恒报,李玉峰,等.血液病患者单采血小板输注疗效及血小板抵抗体分析[J].中华血液病杂志,2017,28(9):635.[2]Bendapudi PK,Hurwitz S,Fry A,et al.Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic micoangiopathies:a cohort study[J].Lancet Haematol,2017(17):S2352-S3026.[3]张磊,陈丽萌.血液净化治疗多发性骨髓瘤肾脏损害[J].基础医学与临床,2018,38(1):112-117.[4]杨建兵,彭李,李明鹏,等.血液净化对多发性骨髓瘤并急性肾损伤的疗效分析[J].中国肿瘤临床与康复,2016,23(7):806-809.[5]吴继博,马峰,岳彦伟,等.不规则抗体筛查阳性患者输血策略的探讨[J].中国输血杂志,2018,31(8):831-833.[6]Pandey CK,Saluja V,Gaurav K,et al.K time & maximum amplitude of thromboelastogram predict post-central venous cannulation bleeding in patients with cirrhosis:A pilot study[J].Indian J Med Res,2017,145(1):84-89.[7]任明臣,李敏,李娟,等.溶血性贫血患者行不同制备方法的成分输血的临床效果分析[J].实用医药杂志,2018,35(11):1008-1010.[8]沈祖建.成分输血对慢性贫血患者临床症状及血红蛋白、红细胞水平的改善作用[J].中外医学研究,2018,16(13):61-63.[9]胡文静,周荣富,贾璐,等.不同血液病患者发生自性出血事件时的血小板特征[J].江苏医药,2017,42(11):1258-1260.[10]符小玲,蔡兴权,夏兰,等.血液病患者单采血小板输注疗效的影响因素分析[J].现代生物医学进展2018,8(3):139-141.[11]李志静.反复输注血小板的血液病患者输血疗效的分析[J].中国输血杂志,2018,25(3):222-225.[12]黄蓉.30例血液病患者输血不良反应调查分析[J].医学临床研究,2017,34(6):1225-1226.[13]王芳.血液病患者ABO血型抗原减弱的原因与输血对策分析[J].基层医学论坛,2018(5):662-663.[14]刘洋,崔若帅,马春娅,等.血液病患者血小板输注效果对比及无效原因分析[J].国际检验医学杂志,2017,38(13):1836-1838.[15]张莉萍.输注红细胞对恶性血液病患者淋巴细胞亚群的影响[J].山西医科大学,2016,10(5):64-67.[16]吕慧敏,周丹,张兴丽.可调式采血治疗架在血细胞分离机采血中的设计与应用[J].哈尔滨医科大学学报,2016,50(5):475-476.[17]陈柳.不同输血方法在自身免疫性溶血性贫血患者中的效果及对血清学指标的影响[J].中国药物与临床,2019,19(12):2031-2033.[18]朱理平,朱理佳,王永志,等.526例恶性血液病初诊患者血浆凝血等指标检测的临床意义分析[J].现代检验医学杂志,2020,35(1):105-110.[19]李君君,王颖,黄丽芳,等.治疗性血液成分单采术在血液病中的应用及疗效评价[J].中国现代医药杂志,2016,18(7):28-30.[20]晏佳楠.血液成分单采治疗血液病的临床疗效观察[J].中国卫生标准管理,2016,7(21):62-63.

相似文献/References:

[1]张秀灵,牟春燕,李 武.非生物人工肝支持系统的临床应用现状及进展[J].医学信息,2018,31(02):40.[doi:10.3969/j.issn.1006-1959.2018.02.014]
　ZHANG Xiu-ling,MOU Chun-yan,LI Wu.Current Status and Progress of Clinical Application of Abiotic Artificial Liver Support System[J].Medical Information,2018,31(08):40.[doi:10.3969/j.issn.1006-1959.2018.02.014]
[2]刘燕燕,曾万江,徐晓燕,等.产后并发血栓性血小板减少性紫癜1例报告及文献复习[J].医学信息,2019,32(09):189.[doi:10.3969/j.issn.1006-1959.2019.09.065]
[3]李 鑫,阙文君,余泽波.以冷凝集素综合征为首发表现的淋巴瘤1例[J].医学信息,2020,33(12):188.[doi:10.3969/j.issn.1006-1959.2020.12.064]
[4]郭 婷,王伟新,张丽丽.血浆置换联合分子吸附再循环系统治疗肝衰竭的疗效[J].医学信息,2020,33(24):104.[doi:10.3969/j.issn.1006-1959.2020.24.028]
　GUO Ting,WANG Wei-xin,ZHANG Li-li.The Effect of Plasma Exchange Combined with Molecular Adsorption Recirculation System in the Treatment of Liver Failure[J].Medical Information,2020,33(08):104.[doi:10.3969/j.issn.1006-1959.2020.24.028]
[5]金 英.血浆置换联合大剂量甲泼尼龙对特发性血小板减少性紫癜患者血小板相关免疫球蛋白及T细胞亚群的影响[J].医学信息,2022,35(09):131.[doi:10.3969/j.issn.1006-1959.2022.09.032]
　JIN Ying.Effect of Plasma Exchange Combined with High-dose Methylprednisolone on Platelet-related Immunoglobulin and T Cell Subsets in Patients with Idiopathic Thrombocytopenic Purpura[J].Medical Information,2022,35(08):131.[doi:10.3969/j.issn.1006-1959.2022.09.032]
[6]李 冬,方长太,程高翔.双重血浆分子吸附模式人工肝在重症急性肝衰竭患者中的应用效果[J].医学信息,2022,35(09):147.[doi:10.3969/j.issn.1006-1959.2022.09.037]
　LI Dong,FANG Chang-tai,CHENG Gao-xiang.Application Effect of Dual Plasma Molecular Adsorption System Artificial Liver in Patients with Severe Acute Liver Failure[J].Medical Information,2022,35(08):147.[doi:10.3969/j.issn.1006-1959.2022.09.037]

更新日期/Last Update: 1900-01-01